A case study through the characterization of the essential transcription termination Rho factor from a low G+C, Gram-negative bacterium
A lire aussi
A new anticancer therapeutic strategy targeting the protein kinases LIMKs via new innovative chemical compounds
29 October 2024
par Isabelle Frapart
2024, November 15 - Seminar of Gyula TIRCSO
25 October 2024
par Isabelle Frapart
2024, November 8 - Seminar of Sophia MISSOURRY
25 October 2024
par Isabelle Frapart